People

Susan Desmond-Hellman, MD, MPH, has been chosen to be the next CEO of the Bill & Melinda Gates Foundation, succeeding Jeff Raikes. Based in Seattle, WA, the Gates Foundation is the largest philanthropic organization in the world, with $40 billion in assets to put toward its global health and economic development activities. Desmond-Hellman will assume her new role on May 1.

An oncologist by training, Desmond-Hellman has served as chancellor of the University of California, San Francisco (UCSF), since 2009, overseeing all aspects of the university and the medical center. Prior to her tenure at UCSF, she was president of product development at Genentech, where she led the development and introduction of two of the first targeted therapies for cancer, Avastin (bevacizumab) and Herceptin (trastuzumab).

Steven T. Rosen, MD, has been named provost and chief scientific officer at City of Hope in Duarte, CA. He will be responsible for its National Cancer Institute (NCI)–designated comprehensive cancer center, the Beckman Research Institute, and for the Irell and Manella Graduate School of Biological Sciences. He will start his new position on March 1.

An internationally known specialist in hematologic malignancies, Rosen has spent 32 years at the Northwestern University Feinberg School of Medicine in Chicago, IL, and has served as director of its Robert H. Lurie Comprehensive Cancer Center since 1989. In addition, he is the current co-principal investigator of Northwestern's NCI-funded Center for Cancer Nanotechnology Excellence.

Rosen's research has focused on experimental therapeutics for blood cancers. He has published more than 400 papers, editorials, books, and book chapters. He sits on the national board of the Leukemia & Lymphoma Society.

For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.